If startup funding rounds are any metric, generative AI is seeing ample adoption in the sciences. It makes sense: there’s a lot of trial and error involved in ...

SUMMIT, N.J. & OAKLAND, Calif.--(BUSINESS WIRE)-- Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (KVUE), maker of consumer health products like Zyrtec®, ...

SUMMIT, N.J. & OAKLAND, Calif., October 14, 2025--(BUSINESS WIRE)--Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE: KVUE), maker of consumer health ...

Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Zyrtec®, Neutrogena®, and Listerine®, to accelerate ...

TOKYO, September 10, 2025--(BUSINESS WIRE)--Albert Invent, whose world-leading end-to-end artificial intelligence-driven platform is transforming R&D in the chemical and materials industries, today ...

Kenvue Inc. (NYSE:KVUE) is included among the 11 Low PE High Dividend Stocks to Buy According to Analysts. Kenvue Inc. (NYSE:KVUE) is among the best dividend stocks according to analysts, with an ...

TOKYO--(BUSINESS WIRE)--Albert Invent, whose world-leading end-to-end artificial intelligence-driven platform is transforming R&D in the chemical and materials industries, today announced the launch ...

OAKLAND, Calif.--(BUSINESS WIRE)--Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science using AI, today announced a $22.5 million Series A funding round led ...